Latest Trials Latest NewsFAQ

ALCON RESEARCH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis

Phase 3

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: Olopatadine hydrochloride ophthalmic solution, 0.2%
Drug: Olopatadine hydrochloride ophthalmic solution, 0.1%
Drug: AL-4943A ophthalmic solution
Drug: AL-4943A ophthalmic solution vehicle

First Posted Date: 2012-12-06

Last Posted Date: 2014-08-11

Lead Sponsor: Alcon Research

Target Recruit Count: 902

Registration Number: NCT01743027

SYSTANE® Family - Meibomian Deficiency

Not Applicable

Completed

Conditions: Dry Eye Syndrome

Interventions: Other: Microfiber towels (as warm compresses, with or without saline eye drops)
Other: SYSTANE® Lid Wipes
Other: SYSTANE® BALANCE
Dietary Supplement: SYSTANE® Vitamins

First Posted Date: 2012-11-27

Last Posted Date: 2018-06-29

Lead Sponsor: Alcon Research

Target Recruit Count: 26

Registration Number: NCT01733745

SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers

Not Applicable

Completed

Conditions: Dry Eye Syndrome

Interventions: Other: SYSTANE® Gel
Other: SYSTANE® BALANCE Lubricant Eye Drops

First Posted Date: 2012-11-27

Last Posted Date: 2018-06-29

Lead Sponsor: Alcon Research

Target Recruit Count: 54

Registration Number: NCT01733732

The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects

Not Applicable

Completed

Conditions: Dry Eye

Interventions: Other: Propylene glycol 0.6% ocular emulsion
Other: Sodium chloride 0.9% saline solution

First Posted Date: 2012-10-31

Last Posted Date: 2014-01-06

Lead Sponsor: Alcon Research

Target Recruit Count: 51

Registration Number: NCT01718028

Locations: 🇦🇷
Consultório Oftalmológico, Martinez, Buenos Aires, Argentina

Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems

Not Applicable

Completed

Conditions: Refractive Error
Myopia
Astigmatism

Interventions: Device: Lotrafilcon B contact lenses
Device: Senofilcon A contact lenses
Device: OPTI-FREE® PUREMOIST® MPDS
Device: BIOTRUE®
Device: Balafilcon A contact lenses
Device: ReNu® Multiplus®

First Posted Date: 2012-10-04

Last Posted Date: 2014-12-08

Lead Sponsor: Alcon Research

Target Recruit Count: 109

Registration Number: NCT01699750

Locations: 🇺🇸
Contact Alcon Call Center at 1-888-451-3937 for Trial Locations, Fort Worth, Texas, United States

A Safety and Effectiveness Study of PRK Using the ALLEGRETTO WAVE® EYE-Q Excimer Laser System

Not Applicable

Completed

Conditions: Astigmatism
Myopia

Interventions: Procedure: Photorefractive keratectomy (PRK)
Device: ALLEGRETTO WAVE EYE-Q excimer laser system

First Posted Date: 2012-10-03

Last Posted Date: 2019-09-30

Lead Sponsor: Alcon Research

Target Recruit Count: 176

Registration Number: NCT01699087

A Six-Week Safety Study of an Investigational Ophthalmic Solution

Phase 3

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: AL-4943A Ophthalmic Solution
Drug: AL-4943A Ophthalmic Solution Vehicle

First Posted Date: 2012-10-03

Last Posted Date: 2014-03-27

Lead Sponsor: Alcon Research

Target Recruit Count: 518

Registration Number: NCT01698814

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients

Phase 4

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: Olopatadine hydrochloride ophthalmic solution, 0.2%

First Posted Date: 2012-10-02

Last Posted Date: 2014-08-18

Lead Sponsor: Alcon Research

Target Recruit Count: 17

Registration Number: NCT01697969

Locations: 🇺🇸
University of Iowa, Iowa City, Iowa, United States

Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia

Phase 4

Withdrawn

Conditions: Glaucoma
Ocular Hypertension

Interventions: Drug: Travoprost 0.004%/Timolol 0.5% Fixed Combination (DuoTrav)

First Posted Date: 2012-10-01

Last Posted Date: 2013-02-07

Lead Sponsor: Alcon Research

Registration Number: NCT01696383

Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency

Not Applicable

Completed

Conditions: Dry Eye Syndrome
Lipid Deficiency

Interventions: Other: SYSTANE® BALANCE eyedrops
Other: Minims® Saline 0.9% eyedrops

First Posted Date: 2012-09-20

Last Posted Date: 2018-06-29

Lead Sponsor: Alcon Research

Target Recruit Count: 91

Registration Number: NCT01688726

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy